NCT05896085 is a NA clinical trial of REThink game in Assessment, sponsored by Babes-Bolyai University.

Who is sponsoring NCT05896085?

NCT05896085 is sponsored by Babes-Bolyai University.

What drugs are being tested in NCT05896085?

Interventions in NCT05896085: REThink game.

What condition does NCT05896085 study?

NCT05896085 studies Assessment, Emotion Regulation.

Is NCT05896085 still recruiting?

NCT05896085 is currently completed. Last updated 6 December 2023.

Last reviewed 2023-12-06 · How we verify

NCT05896085

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Game Based Assessment of Emotion-regulation Skills in College Students

Completed NA Last updated 6 December 2023

What this trial tests

NA trial testing REThink game in Assessment in 290 participants. Completed in 29 November 2023.

Timeline

1 July 2023

Primary endpoint
29 November 2023

29 November 2023

Quick facts

Lead sponsor	Babes-Bolyai University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	290
Start date	1 July 2023
Primary completion	29 November 2023
Estimated completion	29 November 2023
Sites	1 location across Romania

Drugs / interventions tested

REThink game

Conditions studied

Assessment — all drugs for Assessment →
Emotion Regulation — all drugs for Emotion Regulation →

Sponsor

Babes-Bolyai University

Who can join

18 and older, any sex, with Assessment or Emotion Regulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study will be to investigate the validity of the in-game performance measurements or scores as indicators of students'ER abilities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Babes-Bolyai University trials

Trials by the same sponsor.

NCT06646159 — REThink for Mental Health of the Youths in Romania · NA · not yet recruiting
NCT06810999 — From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms. · NA · not yet recruiting
NCT06961695 — The Efficacy of a Mindfulness-Based Virtual Reality Intervention to Reduce Pain in Postoperative Patients · NA · not yet recruiting
NCT06724666 — Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression · NA · recruiting
NCT06986928 — A Network Analysis on the Role of Specific ER Abilities as ERFs for Distress and Mental Health, in Relation to CAs Expos · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05896085 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Babes-Bolyai University
Last refreshed: 6 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05896085.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing